معرفی
Hanne Røland Hagland is an Associate Professor in Biochemistry at the University of Stavanger (Department of Chemistry, Life Sciences and Environmental Technology). She leads a research group focused on cancer cell metabolism, particularly mitochondrial contributions to tumor growth adaptation and treatment response. Her work bridges basic research with clinical applications through collaborations with Stavanger University Hospital in translational oncology. She employs advanced technologies like 3D bioprinting for organoid modeling and state-of-the-art equipment for mitochondrial analysis. Hagland teaches cell biology courses and supervises graduate students in biological chemistry programs.
Education: BSc Molecular Genetics (Sussex University), MSc Medical Cell Biology (University of Bergen), PhD in Mitochondrial Flexibility in Cancer (2012, Bergen). Postdoctoral work at Stavanger University Hospital established biobanks for clinical research. Since 2015, she has built her independent research group at UiS, focusing on mitochondrial fitness in cancer and novel therapeutic strategies.
Research emphasizes mitochondrial adaptations in cancer cells, 3D bioprinting for tumor modeling, and personalized medicine approaches. Key techniques include metabolic flux analysis, organoid culture, and graphene-based drug delivery systems. She actively seeks interdisciplinary collaborations to advance cancer treatment strategies.
Recent articles highlight drug sensitivity in 3D tumor models, graphene applications in drug carriers, and metabolic differences between 2D/3D cultures. Her work contributes to understanding how mitochondrial biology influences cancer treatment outcomes.
Labs/Teams: Maintains advanced facilities with 3D bioprinters, mitochondrial analysis equipment, and gene/protein expression tools. Collaborates with clinicians and engineers to integrate novel technologies into cancer research.
